Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Views - The report highlights that the prices of methionine and vitamins are currently at historical lows, with expectations for a rebound in prices supported by cost factors and stable demand growth. Companies with cost and scale advantages are likely to see profit recovery [6] Summary by Sections Methionine - Since January 2026, methionine prices have rebounded due to strong pricing attitudes from factories amid downstream stocking for the Spring Festival, with prices reaching 18.50 CNY/kg. The average prices for solid and liquid methionine in February 2026 are 18.50 CNY/kg and 14.30 CNY/kg, respectively, reflecting year-on-year declines of 15.5% and 7.7% [4][9] - The domestic export volume of methionine in 2025 was 319,000 tons, up 22.7% year-on-year, while imports were 182,000 tons, up 13.8% year-on-year. The net export volume increased by 37,000 tons year-on-year [4] - Global methionine production capacity is 2.6 million tons, with China accounting for 1.07 million tons (41%). The top three companies (Evonik, ADM, and New Hope Liuhe) hold a 74% market share [12][14] Vitamins - The report indicates that the supply-demand imbalance for vitamins has intensified, with current prices at historical lows. Manufacturers are maintaining a firm pricing stance due to low inventory levels among distributors and increased export demand [5] - As of February 9, 2026, the market prices for various vitamins are as follows: VA (60.5 CNY/kg), VE (57.0 CNY/kg), VD3 (195.0 CNY/kg), and VB6 (107.5 CNY/kg), with historical percentiles indicating low pricing levels [8] - The report notes that the price of vitamin E has seen a rebound due to factors such as low inventory and increased demand from downstream sectors [5] Investment Recommendations - The report recommends focusing on companies with strong positions in methionine (e.g., New Hope Liuhe, Hebang Biotechnology) and vitamins (e.g., New Hope Liuhe, Zhenhua Co., Ltd.) as potential beneficiaries of the expected price recovery [6]

Investment Rating - The report maintains an "Optimistic" rating for the chemical industry [2][3] Core Insights - The report highlights an upward trend in the dye, PVA, and vitamin sectors, with price increases expected post-holiday. It emphasizes the importance of positioning in the spring chemical sector [2][3] - Oil prices are expected to remain in a relatively loose range, supported by a stronger bottom, with Brent crude projected between $55-70 per barrel. Coal prices are stabilizing, and natural gas costs are anticipated to decline due to increased export facilities in the U.S. [2][3] - The report suggests focusing on specific sectors such as textiles, agriculture, exports, and beneficiaries of "anti-involution" policies for investment opportunities [2][3] Summary by Sections Industry Dynamics - Current macroeconomic judgment indicates that oil supply is slowing due to OPEC+ production delays and peak shale oil output. Demand is stabilizing with global economic improvements, leading to a forecast of stable oil demand [3][4] - The chemical industry is experiencing a recovery phase, with PPI showing a slight increase and manufacturing PMI at 49.3%, indicating some volatility in manufacturing operations [4] Investment Analysis - The report recommends investments in the textile chain, agricultural chain, export chain, and sectors benefiting from anti-involution policies. Specific companies to watch include: - Textiles: Lu Xi Chemical, Tongkun Co., Rongsheng Petrochemical, Hengli Petrochemical - Agriculture: Hualu Hengsheng, Baofeng Energy, Yuntianhua, Xingfa Group - Exports: Juhua Co., Sanmei Co., Wanhu Chemical, and others [2][3] - Key materials for growth include semiconductor materials, panel materials, and biobased materials, with specific companies highlighted for each category [2][3] Key Company Valuations - The report provides a valuation table for key companies, indicating their market capitalization and projected earnings for 2024-2027, with recommendations for "Increase" or "Buy" ratings for several firms [15][16]

Investment Rating - The report maintains an "Optimistic" rating for the chemical industry [2][3] Core Insights - The chemical macroeconomic outlook indicates a stable increase in oil demand due to global economic recovery, with Brent crude oil expected to remain in the range of $55-70 per barrel [2][3] - The dye, PVA, and vitamin sectors are experiencing upward trends, with price increases anticipated post-holiday, highlighting the importance of positioning in the spring chemical sector [2][3] - The report suggests focusing on specific companies within the textile, agricultural, export, and "anti-involution" sectors for investment opportunities [2][3] Summary by Relevant Sections Chemical Macro Outlook - Oil supply is constrained due to OPEC+ production delays and peak shale oil output, while demand is stabilizing with tariff adjustments and economic improvements [2][3] - Coal prices are expected to stabilize at a long-term bottom, and natural gas costs may decrease as the U.S. accelerates export facility construction [2][3] Price Trends and Recommendations - Dye prices are expected to rise significantly, with companies like Zhejiang Longsheng and Runtu Co. recommended for investment [2][3] - PVA prices have increased from 9,530 CNY/ton to 10,244 CNY/ton, indicating further upward potential, with a focus on Anhui Wuhua [2][3] - Vitamin E prices are projected to rise post-holiday due to production halts during the Chinese New Year, with New Hope Liuhe recommended [2][3] Investment Strategy - The report recommends a diversified investment approach across four main chains: textile, agricultural, export, and sectors benefiting from "anti-involution" policies [2][3] - Key companies to watch include: - Textile: LUXI Chemical, Tongkun Co., and Hengli Petrochemical - Agricultural: Hualu Hengsheng, Baofeng Energy, and Yuntianhua - Export-related chemicals: Juhua Co., Wanhua Chemical, and leading titanium dioxide producers [2][3] Growth Focus - Emphasis on self-sufficiency in key materials, particularly in semiconductor and panel materials, with companies like Yake Technology and Dingsheng Co. highlighted [2][3]

Summary of Key Points Industry Overview - The documents focus on the vitamin and amino acid industry, specifically highlighting the activities of a company named 新和成 (New Hope Liuhe) in the production and pricing of Vitamin E (VE) and methionine. Core Insights and Arguments - **Vitamin E Price Increase**: 新和成 has raised the export price of feed-grade Vitamin E by 15% effective from February 5. This price adjustment is attributed to strong overseas demand, with China's Vitamin E export volume projected to reach 14,436.80 tons by December 2025, marking a year-on-year increase of 39.12% and a quarter-on-quarter increase of 28.44% [1][1][1]. - **Methionine Price Increase**: Starting February 3, 新和成 has also increased the export price of solid methionine by 8% [1][1][1]. - **Current Pricing Levels**: The prices for methionine and Vitamin A are currently at historical lows, with Vitamin A priced at 61.5 yuan/kg and methionine at 18.1 yuan/kg, which are at the 0.1% and 1% historical price percentiles respectively. This indicates a significant potential for upward price elasticity [1][1][1]. - **Production Capacity**: 新和成 has a production capacity of 550,000 tons of methionine, 8,000 tons of Vitamin A, 60,000 tons of Vitamin E, and 2,000 tons of Vitamin D3 [1][1][1]. - **Profitability of Methionine**: According to Baichuan Information, the theoretical daily profit for methionine stands at 3,790 yuan/ton, which is at the 10% historical price difference percentile [1][1][1]. Additional Important Content - **Current Financial Status of Vitamin A Producers**: Vitamin A production companies are currently operating at the breakeven point, indicating a challenging financial environment [2][2][2]. - **Risk Factors**: There are several risk factors highlighted, including potential underperformance in terminal demand, unexpected increases in raw material prices, and delays in project implementation [3][3][3].

Investment Rating - The report maintains an "Overweight" rating for the oil and gas sector and the basic chemicals sector [5]. Core Insights - The overall price spread in the industry improved in January, indicating a potential recovery in profitability for 2026, with the CCPI-raw material price spread reaching 2631, up from 2500 at the end of 2025 [1][9]. - The demand for chemical products is shifting from real estate to consumer goods, infrastructure, and emerging technologies, with significant growth potential driven by global economic trends [2][11]. - The capital expenditure growth in the chemical industry has been declining since June 2025, suggesting a supply-side adjustment is approaching, which may lead to improved profitability in the sector [2][16]. Summary by Sections Price Trends - In January, oil prices rose due to geopolitical tensions and strong global crude oil replenishment demand, leading to a slight improvement in the price spread of most chemical products [9][21]. - Major price increases were observed in products like lithium carbonate and butadiene, while some products like methyltrichlorosilane saw price declines due to supply adjustments [3][33]. Supply and Demand Dynamics - The January PMI was reported at 49.3, indicating a continued bottoming out in the real estate sector, while consumer goods and major infrastructure showed positive growth [2][11]. - The chemical industry is expected to see a recovery in demand, supported by the exit of high-energy-consuming facilities in Europe and North America, and economic growth in Asia, Africa, and Latin America [2][11][14]. Investment Strategy - The report suggests focusing on sectors with potential recovery, such as oil and gas, basic chemicals, and companies leveraging synthetic biology for cost reduction [32]. - Specific stock recommendations include China Petroleum & Chemical Corporation, Baofeng Energy, and Yun Tianhua, among others, highlighting their potential for growth and profitability [7][32]. Monthly Performance Review - In January, the basic chemical index rose by 12.72%, with significant gains in sub-sectors like dye chemicals and petrochemical raw materials [34][36]. - The report notes that the chemical industry is experiencing a recovery phase, with various sub-sectors showing positive price movements and improved market conditions [34][36].

1. Industry Investment Rating No investment rating information is provided in the report. 2. Core Viewpoints The report presents a comprehensive analysis of the basic chemical industry's weekly data, covering price and profit changes in multiple sectors such as polyurethane, oil - gas - olefin, coal - chemical, and animal nutrition, and also tracks the stock price performance and profitability of related listed companies [1][2][8]. 3. Summary by Directory 3.1 Basic Chemical Weekly Data Briefing - **Related Company Performance Tracking**: - **Stock Price Changes**: The basic chemical index decreased by 2.1% in the past week, increased by 9.0% in the past month, 17.6% in the past three months, 48.7% in the past year, and 10.4% since the beginning of 2026. Among the related listed companies, New Hope Liuhe Co., Ltd. (002001.SZ) had a 6.8% increase in the past week, while other companies such as Wanhua Chemical Group Co., Ltd. (600309.SH) and Baofeng Energy Group Co., Ltd. (600989.SH) had varying degrees of decline [8]. - **Profitability**: The report provides the total market value, stock price, net profit attributable to the parent company, PE, and PB of related listed companies from 2024A to 2027E [8]. - **Industry Chain Data**: - **Polyurethane Industry Chain**: This week, the average prices of pure MDI, polymer MDI, and TDI were 17,500 yuan/ton, 13,900 yuan/ton, and 14,377 yuan/ton respectively. The corresponding weekly changes were - 43 yuan/ton, + 36 yuan/ton, and + 292 yuan/ton, and the gross margins were 4,097 yuan/ton, 1,497 yuan/ton, and 2,345 yuan/ton respectively [2][8]. - **Oil - Gas - Olefin Industry Chain**: The average prices of ethane, propane, steam coal, and naphtha were 1,277 yuan/ton, 4,399 yuan/ton, 520 yuan/ton, and 4,137 yuan/ton respectively, with weekly changes of - 139 yuan/ton, + 51 yuan/ton, 0 yuan/ton, and + 63 yuan/ton. The theoretical profits of polyethylene production through different processes and polypropylene production through different processes also had corresponding changes [2][8]. - **Coal - Chemical Industry Chain**: The average prices of synthetic ammonia, urea, DMF, and acetic acid were 2,119 yuan/ton, 1,758 yuan/ton, 4,004 yuan/ton, and 2,511 yuan/ton respectively, with weekly changes of - 65 yuan/ton, + 13 yuan/ton, + 41 yuan/ton, and - 69 yuan/ton. The corresponding gross margins also changed [2]. - **Animal Nutrition Industry Chain**: The average prices of VA, VE, solid methionine, and liquid methionine were 61.4 yuan/kg, 55.9 yuan/kg, 18.2 yuan/kg, and 14.3 yuan/kg respectively, with weekly changes of - 0.1 yuan/kg, + 0.9 yuan/kg, + 0.3 yuan/kg, and + 0.1 yuan/kg [2][9]. 3.2 Basic Chemical Weekly Report - **Basic Chemical Index Trend**: The report does not elaborate on the basic chemical index trend but focuses on the performance data of the index and related companies [8]. - **Polyurethane Plate**: Analyzes the price trends and price - spread situations of pure MDI, polymer MDI, and TDI in China [16][19]. - **Oil - Gas - Olefin Plate**: Discusses the price trends of raw materials such as ethane, propane, natural gas, and crude oil, as well as the profitability of different processes for producing polyethylene and polypropylene [23][31][38]. - **Coal - Chemical Plate**: Covers the price and gross margin trends of coal - coking products and traditional coal - chemical products, as well as some new materials [40][45][52]. - **Animal Nutrition Plate**: Analyzes the price trends of VA, VE, solid methionine, and liquid methionine [57][59][63].

Group 1 - The A-share market opened lower but saw the pharmaceutical sector rebound, with the only ETF tracking the pharmaceutical index recovering its 10-day moving average and aiming for a four-day winning streak [1] - The Ministry of Industry and Information Technology, along with eight other departments, issued a plan for the high-quality development of traditional Chinese medicine, outlining a development blueprint for 2026-2030 [2] - The report highlights a positive outlook for the pharmaceutical sector driven by policy support, cost improvements, and expectations for adjustments in the basic drug catalog [3] Group 2 - The report indicates that the raw material drug sector is favored, with innovative drug segments such as small nucleic acids, peptides, and ADC toxins driving continuous industry chain catalysts [3] - The pharmaceutical ETF (562050) covers 50 leading pharmaceutical companies, focusing on innovative drugs while also considering traditional Chinese medicine [5] - Notable stock performances include Xinhecheng rising over 7%, and Sanofi Guojian increasing by more than 5%, with traditional Chinese medicine stocks like Darentang and Yiling Pharmaceutical also seeing gains of over 4% [5]

格隆汇2月6日丨新和成(002001.SZ)涨2.04%，报28.560元，股价创历史新高，总市值877.77亿元。 ...

Group 1 - The company, Zhejiang Xinhengcheng Co., Ltd., has received approval from the China Interbank Market Dealers Association to register and issue debt financing instruments totaling up to 3 billion yuan [1] - The registration for the short-term financing bonds and medium-term notes is valid for two years from the date of the acceptance notice [1] - The company plans to issue its first tranche of technology innovation bonds for the year 2026 on January 30, 2026, with listing and circulation starting on February 3, 2026 [1] Group 2 - The board of directors of the company approved the proposal for debt financing at the 14th meeting of the 9th board on August 26, 2025, and at the second extraordinary general meeting of shareholders on September 12, 2025 [1] - The issuance results and related documents can be found on the China Money website and the Shanghai Clearing House website [1] - The company emphasizes the authenticity, accuracy, and completeness of the information disclosed [2]

浙江新和成股份有限公司 2026 年度第一期科技创新债券发行结果公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：002001 证券简称：新和成 公告编号：2026-004 2025 年 12 月 24 日，公司收到中国银行间市场交易商协会核发的《接受注 册通知书》（中市协注[2025]SCP392 号、中市协注[2025]MTN1264 号），中国 银行间市场交易商协会同意接受公司超短期融资券、中期票据注册，注册自通知 书落款之日起 2 年内有效，在注册有效期内可分期发行。 本次债券发行的有关文件详见中国货币网（www.chinamoney.com.cn）和上 海清算所（www.shclearing.com.cn）网站。 特此公告。 浙江新和成股份有限公司董事会 2026 年 2 月 4 日 浙江新和成股份有限公司（以下简称"公司"）于 2025 年 8 月 26 日召开的 第九届董事会第十四次会议、2025 年 9 月 12 日召开的 2025 年第二次临时股东 大会审议通过《关于申请注册发行债务融资工具的议案》，同意公司向中国银行 间市场交 ...